India Neurodegenerative Disease Market (2025-2031) | Industry, Competitive Landscape, Value, Segmentation, Share, Growth, Trends, Companies, Outlook, Size & Revenue, Analysis, Forecast

Name: India Neurodegenerative Disease Market (2025-2031) | Industry & Competitive Landscape
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor Antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) And Competitive Landscape

Product Code: ETC7548795	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

India Neurodegenerative Disease Market Outlook
Market Size of India Neurodegenerative Disease Market, 2024
Forecast of India Neurodegenerative Disease Market, 2031
Historical Data and Forecast of India Neurodegenerative Disease Revenues & Volume for the Period 2021- 2031
India Neurodegenerative Disease Market Trend Evolution
India Neurodegenerative Disease Market Drivers and Challenges
India Neurodegenerative Disease Price Trends
India Neurodegenerative Disease Porter's Five Forces
India Neurodegenerative Disease Industry Life Cycle
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Indication Type for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Parkinson's Disease for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Alzheimer's Disease for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Multiple Sclerosis for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Huntington Disease for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Other Indication Types for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Drug Type for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By N-methyl-D-aspartate Receptor Antagonists for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Cholinesterase Inhibitors for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Dopamine Agonists for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Immunomodulatory Drugs for the Period 2021- 2031
Historical Data and Forecast of India Neurodegenerative Disease Market Revenues & Volume By Other Drug Types for the Period 2021- 2031
India Neurodegenerative Disease Import Export Trade Statistics
Market Opportunity Assessment By Indication Type
Market Opportunity Assessment By Drug Type
India Neurodegenerative Disease Top Companies Market Share
India Neurodegenerative Disease Competitive Benchmarking By Technical and Operational Parameters
India Neurodegenerative Disease Company Profiles
India Neurodegenerative Disease Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 India Neurodegenerative Disease Market Overview

3.1 India Country Macro Economic Indicators

3.2 India Neurodegenerative Disease Market Revenues & Volume, 2021 & 2031F

3.3 India Neurodegenerative Disease Market - Industry Life Cycle

3.4 India Neurodegenerative Disease Market - Porter's Five Forces

3.5 India Neurodegenerative Disease Market Revenues & Volume Share, By Indication Type, 2021 & 2031F

3.6 India Neurodegenerative Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

4 India Neurodegenerative Disease Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurodegenerative diseases in India

4.2.2 Rising geriatric population in the country

4.2.3 Growing awareness and focus on healthcare and treatment options for neurodegenerative diseases

4.3 Market Restraints

4.3.1 Limited access to specialized healthcare services in rural areas of India

4.3.2 High cost of treatment and medications for neurodegenerative diseases

4.3.3 Lack of trained healthcare professionals in neurology and geriatrics

5 India Neurodegenerative Disease Market Trends

6 India Neurodegenerative Disease Market, By Types

6.1 India Neurodegenerative Disease Market, By Indication Type

6.1.1 Overview and Analysis

6.1.2 India Neurodegenerative Disease Market Revenues & Volume, By Indication Type, 2021- 2031F

6.1.3 India Neurodegenerative Disease Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F

6.1.4 India Neurodegenerative Disease Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F

6.1.5 India Neurodegenerative Disease Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F

6.1.6 India Neurodegenerative Disease Market Revenues & Volume, By Huntington Disease, 2021- 2031F

6.1.7 India Neurodegenerative Disease Market Revenues & Volume, By Other Indication Types, 2021- 2031F

6.2 India Neurodegenerative Disease Market, By Drug Type

6.2.1 Overview and Analysis

6.2.2 India Neurodegenerative Disease Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F

6.2.3 India Neurodegenerative Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F

6.2.4 India Neurodegenerative Disease Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.2.5 India Neurodegenerative Disease Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F

6.2.6 India Neurodegenerative Disease Market Revenues & Volume, By Other Drug Types, 2021- 2031F

7 India Neurodegenerative Disease Market Import-Export Trade Statistics

7.1 India Neurodegenerative Disease Market Export to Major Countries

7.2 India Neurodegenerative Disease Market Imports from Major Countries

8 India Neurodegenerative Disease Market Key Performance Indicators

8.1 Number of research studies and clinical trials conducted on neurodegenerative diseases in India

8.2 Percentage of government healthcare budget allocated towards neurodegenerative disease research and treatment

8.3 Number of neurology specialists and geriatricians per capita in India

9 India Neurodegenerative Disease Market - Opportunity Assessment

9.1 India Neurodegenerative Disease Market Opportunity Assessment, By Indication Type, 2021 & 2031F

9.2 India Neurodegenerative Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F

10 India Neurodegenerative Disease Market - Competitive Landscape

10.1 India Neurodegenerative Disease Market Revenue Share, By Companies, 2024

10.2 India Neurodegenerative Disease Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Neurodegenerative Disease Market

Costa Rica Neurodegenerative Disease Market

Croatia Neurodegenerative Disease Market

Cuba Neurodegenerative Disease Market

Cyprus Neurodegenerative Disease Market

Denmark Neurodegenerative Disease Market

Global Neurodegenerative Disease Market

Middle East Neurodegenerative Disease Market

North America Neurodegenerative Disease Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here